Fact. MR’s latest report on Gene Delivery Systems Market provides a detailed analysis of growth drivers, market restraints, and emerging trends. It also offers insights into various strategies employed by key market players to gain a competitive edge in the Gene Delivery Systems Market.
Rockville, MD, March 15, 2023 (GLOBE NEWSWIRE) — As per the latest industry analysis by Fact.MR, a market research and competitive intelligence provider, global demand for gene delivery systems is forecasted to increase rapidly at a CAGR of 6.5% from 2022 to 2027.
The requirement for advanced technologies for targeted therapies is driving the global market for gene delivery systems. The introduction of new and cutting-edge technologies and the rise in the prevalence of chronic diseases are the key drivers for market growth. Growing research and development activities in genomics have also been a major factor driving market expansion. Rising preference among patients for modern products and innovative drug delivery systems, because of these products’ increased efficacy and precision, is predicted to boost market value over the coming years.
Download Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7721
The oral route of administration is a cost-effective, painless, and self-administered delivery method that does not require sterile precautions. Market expansion is being boosted by the discovery of new therapies that can recognize afflicted cells and can treat them without damaging the healthy cells. Market growth is also attributed to the quick development of biosimilars, targeted treatments, and gene therapies.
A surge in investments in the sector are supporting the production of various mechanisms of gene transfer. Currently, viral vectors are used in over 70% of gene and cell therapy studies, which is driving organic revenue growth for biological delivery technologies.
Report Attributes
| Details |
| Forecast Period | 2022 – 2027 |
| Value Projection (2027) | US$ 4.1 Billion |
| Growth Rate (2022-2027) | 6.5% CAGR |
| No. of Pages | 170 pages |
| No. of Tables | 84 Tables |
| No. of Figures | 112 Figures |
Key Takeaways from Market Study
- The gene delivery systems market in Japan is projected to evolve at a CAGR of 6% over the forecast period (2022-2027).
- The global gene delivery systems market is predicted to reach US$ 4.1 billion by 2027.
- Market in Germany is forecasted to rise at a CAGR of 5.5% through 2027.
- Demand for non-viral gene delivery systems is predicted to increase at a CAGR of 4.5% from 2022 to 2027.
“Growing usage of viral gene delivery systems to treat illnesses caused by a genetic mutation, constant innovations in gene delivery technologies, increasing acceptance of gene-based medicines, and rising initiatives by government organizations for the development of gene delivery methods are factors expected to boost market revenue over the coming years,” says a Fact.MR analyst
Which Region Spearheads Gene Delivery System Demand?
Higher Consumer Awareness of Improved Drug Delivery Systems North America
North America drives the gene delivery systems market. The market is extending because of rising interest for biological gene delivery systems, rising reception of imaginative items, and rising customer familiarity with further developed drug conveyance frameworks.
Increased prevalence of chronic diseases, technological advancements in genetic analyzer systems, and the presence of key players are driving market growth in the region.
Increasing rates of hospitalizations, technological advancements in drug delivery systems, and rising research and innovation initiatives for the development of gene delivery systems are driving market expansion in the region.
Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=7721
Key Companies Profiled in Gene Delivery Systems Market report
- Amgen, Inc.
- Bayer AG
- Pfizer, Inc.
- Novartis AG
- Johnson & Johnson
- Human Stem Cells Institute
- Oxford Biomedica plc
- Shanghai Sunway Biotech Co., Ltd.
- Sibiono GeneTech Co. Ltd.
Winning Strategy
Top market players are making major investments to expand their viral vector production capacity and keep up with the rising demand. Major players in the genomics industry are focused on the introduction of innovative gene delivery systems. Key companies are engaged in the R&D and commercialization of advanced therapies.
For instance,
- In 2021, Thermogelling peptide delivery methods, which are given as fluid sol at room temperature through an injection, were created by Novartis AG. The company also manufactures ZYKADIA, a medication for the treatment of non-small cell lung cancer.
- Nanoparticles demonstrated their effectiveness as prospective carriers for clinical utilization due to their customizable shape and biological activities.
- Brammer Bio, a company that produces viral vectors for gene therapies, was acquired by Thermo Fisher Scientific.
Segments of Gene Delivery Systems Industry Research
- By Delivery :
- Viral Gene Delivery
- Non-viral Gene Delivery
- By Route of Administration :
- Oral
- Injectable
- Inhalation
- Transdermal
- Ocular
- Nasal
- Others
- By Application :
- Infectious Diseases
- Oncology
- CVD
- Urology
- CNS
- Others
Quick Buy & Expand Your Horizons (Get 20% Discount):
https://www.factmr.com/checkout/7721
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global gene delivery systems market, presenting historical demand data (2017-2021) and forecast statistics for the period of 2022-2027.
The study divulges essential insights on the market on the basis of delivery (viral gene delivery, non-viral gene delivery), route of administration (oral, injectable, inhalation, transdermal, ocular, nasal, others), and application (infectious diseases, oncology, CVD, urology, CNS, others), across five major regions (North America, Europe, Asia Pacific, Latin America, and MEA).
Explore More Related Studies Published by Fact.MR Research:
Gene Therapy Market : The worldwide gene therapy market is scheduled to secure a valuation of US$ 1.85 Billion of every 2022, up from US$ 1.55 Billion out of 2021, addressing a Y-o-Y increment of 19.3%. From 2022-2032, the market is ready to enlist a CAGR of 18.5%, arriving at a valuation of US$ 10.1 Billion.
Epigenetics Market: worldwide epigenetics market in 2022 is esteemed at US$ 992.8 million and is supposed to accomplish an expected income all out of US$ 2.79 billion toward the conjecture time frame’s end. Interest for epigenetics is anticipated to increment at a noteworthy CAGR of 10.9% from 2022 to 2032.
Genetic Testing Services Market: Expanding at a CAGR of 8%, the global genetic testing services market is predicted to increase from a valuation of US$ 40 billion in 2023 to US$ 87 billion by the end of 2033.
CRISPR and Cas Genes Market: Global demand for CRISPR and Cas genes is anticipated to surge at a stupendous CAGR of 20% from 2023 to 2033.
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Connect to Author: Mr. Shambhu Nath Jha
Email: shambhu@factmr.com
Sales Team: sales@factmr.com
Follow Us: LinkedIn | Twitter | YouTube
- Calcium Sulfate Market is predicted to expand at CAGR of 4.1% to attain stupendous revenue levels for the next decade | Study by Future Market Insights, Inc. - March 28, 2023
- Edge Security Market to exceed $70 Bn by 2032, Says Global Market Insights Inc. - March 28, 2023
- PwC and ReversingLabs Form Strategic Alliance to Bring Software Supply Chain Security to Third Party Risk Management Programs - March 28, 2023
